Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Sakaida

Showing results (61-70 of 332) with videos related to

Pageof 34
Sort By:
Journal of Hepatology|May 24, 2003
Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined dietIsao Sakaida, Masako Tsuchiya, Kotarou Kawaguchi, et al.
Journal of Clinical Biochemistry and Nutrition|June 12, 2020
Bone marrow-derived humoral factors suppress oxidative phosphorylation, upregulate TSG-6, and improve therapeutic effects on liver injury of mesenchymal stem cellsTakashi Miyaji, Taro Takami, Koichi Fujisawa, et al.
Cancer & Metabolism|May 13, 2022
An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cellsKoichi Fujisawa, Taro Takami, Toshihiko Matsumoto, et al.
Journal of Gastroenterology|July 6, 2016
Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysisIsao Sakaida, Shuji Terai, Koji Nakajima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 26, 2011
Splenectomy reduces fibrosis and preneoplastic lesions with increased triglycerides and essential fatty acids in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined dietToshiyuki Oishi, Shuji Terai, Takuya Iwamoto, et al.
International Journal of Molecular Sciences|May 17, 2020
Metabolic Alterations in Spheroid-Cultured Hepatic Stellate CellsKoichi Fujisawa, Taro Takami, Nanami Sasai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 24, 2002
Th1 down-regulation at the single-lymphocyte level in HCV-related liver cirrhosis and the effect of TGF-beta on Th1 response: possible implications for the development of hepatomaEiki Sakaguchi, Kozo Kayano, Makoto Segawa, et al.
Journal of Gastroenterology|June 8, 2002
Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phaseAkiko Akazawa, Isao Sakaida, Shingo Higaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 14, 2002
Effects on liver functions of gastric variceal therapy by endoscopic ligation using a detachable snare and sclerotherapy with O-ring ligationMakoto Segawa, Isao Sakaida, Yoshifumi Takeo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 2, 2007
The effect of supplementation with branched-chain amino acids in patients with liver cirrhosisYohei Urata, Kosuke Okita, Keiko Korenaga, et al.
Pageof 34

Showing results (61-70 of 332) with videos related to

Sort By:
Pageof 34
Journal of Hepatology|May 24, 2003
Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined dietIsao Sakaida, Masako Tsuchiya, Kotarou Kawaguchi, et al.
Journal of Clinical Biochemistry and Nutrition|June 12, 2020
Bone marrow-derived humoral factors suppress oxidative phosphorylation, upregulate TSG-6, and improve therapeutic effects on liver injury of mesenchymal stem cellsTakashi Miyaji, Taro Takami, Koichi Fujisawa, et al.
Cancer & Metabolism|May 13, 2022
An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cellsKoichi Fujisawa, Taro Takami, Toshihiko Matsumoto, et al.
Journal of Gastroenterology|July 6, 2016
Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysisIsao Sakaida, Shuji Terai, Koji Nakajima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 26, 2011
Splenectomy reduces fibrosis and preneoplastic lesions with increased triglycerides and essential fatty acids in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined dietToshiyuki Oishi, Shuji Terai, Takuya Iwamoto, et al.
International Journal of Molecular Sciences|May 17, 2020
Metabolic Alterations in Spheroid-Cultured Hepatic Stellate CellsKoichi Fujisawa, Taro Takami, Nanami Sasai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 24, 2002
Th1 down-regulation at the single-lymphocyte level in HCV-related liver cirrhosis and the effect of TGF-beta on Th1 response: possible implications for the development of hepatomaEiki Sakaguchi, Kozo Kayano, Makoto Segawa, et al.
Journal of Gastroenterology|June 8, 2002
Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phaseAkiko Akazawa, Isao Sakaida, Shingo Higaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 14, 2002
Effects on liver functions of gastric variceal therapy by endoscopic ligation using a detachable snare and sclerotherapy with O-ring ligationMakoto Segawa, Isao Sakaida, Yoshifumi Takeo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 2, 2007
The effect of supplementation with branched-chain amino acids in patients with liver cirrhosisYohei Urata, Kosuke Okita, Keiko Korenaga, et al.
Pageof 34